90 related articles for article (PubMed ID: 24745881)
21. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
Yang SY
Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
[TBL] [Abstract][Full Text] [Related]
22. Parallel screening: a novel concept in pharmacophore modeling and virtual screening.
Steindl TM; Schuster D; Laggner C; Langer T
J Chem Inf Model; 2006; 46(5):2146-57. PubMed ID: 16995745
[TBL] [Abstract][Full Text] [Related]
23. The fourth Paul Ehrlich Lecture. Imaging in theory and praxis: from Paul Ehrlich's receptors to modern roentgen analysis.
Karle IL
Med Res Rev; 1992 Jul; 12(4):297-315. PubMed ID: 1326688
[No Abstract] [Full Text] [Related]
24. Pharmacophore modelling: applications in drug discovery.
Langer T; Hoffmann RD
Expert Opin Drug Discov; 2006 Aug; 1(3):261-7. PubMed ID: 23495846
[TBL] [Abstract][Full Text] [Related]
25. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
Klabunde T; Giegerich C; Evers A
J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
[TBL] [Abstract][Full Text] [Related]
26. Toward a better pharmacophore description of P-glycoprotein modulators, based on macrocyclic diterpenes from Euphorbia species.
Ferreira RJ; dos Santos DJ; Ferreira MJ; Guedes RC
J Chem Inf Model; 2011 Jun; 51(6):1315-24. PubMed ID: 21604687
[TBL] [Abstract][Full Text] [Related]
27. Selective pharmacophore design for alpha1-adrenoceptor subtypes.
MacDougall IJ; Griffith R
J Mol Graph Model; 2006 Sep; 25(1):146-57. PubMed ID: 16406718
[TBL] [Abstract][Full Text] [Related]
28. PharmID: pharmacophore identification using Gibbs sampling.
Feng J; Sanil A; Young SS
J Chem Inf Model; 2006; 46(3):1352-9. PubMed ID: 16711754
[TBL] [Abstract][Full Text] [Related]
29. Ligand-based pharmacophore model of N-Aryl and N-Heteroaryl piperazine alpha 1A-adrenoceptors antagonists using GALAHAD.
Zhao X; Yuan M; Huang B; Ji H; Zhu L
J Mol Graph Model; 2010 Sep; 29(2):126-36. PubMed ID: 20538497
[TBL] [Abstract][Full Text] [Related]
30. [Use of the pharmacophore concept in drug design].
Smiesko M; Remko M
Ceska Slov Farm; 1999 Nov; 48(6):247-51. PubMed ID: 10748739
[TBL] [Abstract][Full Text] [Related]
31. The impact of pharmacophore modeling in drug design.
Guner OF
IDrugs; 2005 Jul; 8(7):567-72. PubMed ID: 15973565
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of pharmacophore screening tools.
Sanders MP; Barbosa AJ; Zarzycka B; Nicolaes GA; Klomp JP; de Vlieg J; Del Rio A
J Chem Inf Model; 2012 Jun; 52(6):1607-20. PubMed ID: 22646988
[TBL] [Abstract][Full Text] [Related]
33. Magic bullets and moving targets: antibiotic resistance and experimental chemotherapy, 1900-1940.
Gradmann C
Dynamis; 2011; 31(2):305-21. PubMed ID: 22332461
[TBL] [Abstract][Full Text] [Related]
34. Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists.
Low CM; Buck IM; Cooke T; Cushnir JR; Kalindjian SB; Kotecha A; Pether MJ; Shankley NP; Vinter JG; Wright L
J Med Chem; 2005 Nov; 48(22):6790-802. PubMed ID: 16250638
[TBL] [Abstract][Full Text] [Related]
35. Modeling flexible pharmacophores with distance geometry, scoring, and bound stretching.
Binns M; de Visser SP; Theodoropoulos C
J Chem Inf Model; 2012 Feb; 52(2):577-88. PubMed ID: 22235879
[TBL] [Abstract][Full Text] [Related]
36. [Not Available].
Hüntelmann AC
Ber Wiss; 2013 Dec; 36(4):354-380. PubMed ID: 33008252
[TBL] [Abstract][Full Text] [Related]
37. Sahachiro Hata (1873-1938) and his contributions to the birth of antimicrobial chemotherapy.
Kawamura I
J Infect Chemother; 2023 May; 29(5):546-548. PubMed ID: 36841329
[TBL] [Abstract][Full Text] [Related]
38. Cancer 'chemotherapia specifica' ninety years after Paul Ehrlich.
Shukla SK; Petrucci F; Caimi S; Alimonti A; Cusumano R
Chemotherapy; 2007; 53(5):309-12. PubMed ID: 17728538
[TBL] [Abstract][Full Text] [Related]
39. An Objective Alternative to IUPAC's Approach To Assign Oxidation States.
Postils V; Delgado-Alonso C; Luis JM; Salvador P
Angew Chem Int Ed Engl; 2018 Aug; 57(33):10525-10529. PubMed ID: 29787636
[TBL] [Abstract][Full Text] [Related]
40. On the meaning of "sensitivity".
Ekins R; Edwards P
Clin Chem; 1997 Oct; 43(10):1824-31. PubMed ID: 9341999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
